1
|
Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea.
|
Trans R Soc Trop Med Hyg
|
1996
|
2.13
|
2
|
The cytokine theory of human cerebral malaria.
|
Parasitol Today
|
1994
|
1.73
|
3
|
Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa?
|
Lancet
|
1996
|
1.60
|
4
|
Proposed link between cytokines, nitric oxide and human cerebral malaria.
|
Parasitol Today
|
1991
|
1.52
|
5
|
Immunizing against toxic malarial antigens.
|
Parasitol Today
|
1994
|
1.40
|
6
|
Nitric oxide and parasitic disease.
|
Adv Parasitol
|
1996
|
1.38
|
7
|
Possible central role of nitric oxide in conditions clinically similar to cerebral malaria.
|
Lancet
|
1992
|
1.20
|
8
|
Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.
|
J Exp Med
|
1992
|
1.13
|
9
|
Variable major lipoprotein is a principal TNF-inducing factor of louse-borne relapsing fever.
|
Nat Med
|
1998
|
1.12
|
10
|
Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum.
|
Am J Pathol
|
1992
|
1.09
|
11
|
Variation in the ICAM1 gene is not associated with severe malaria phenotypes.
|
Genes Immun
|
2008
|
1.07
|
12
|
Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
|
Virology
|
1996
|
1.01
|
13
|
Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.
|
Clin Exp Immunol
|
1988
|
1.00
|
14
|
Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology.
|
Trans R Soc Trop Med Hyg
|
1993
|
0.98
|
15
|
Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes.
|
Neurology
|
1986
|
0.93
|
16
|
Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis.
|
J Infect Dis
|
1994
|
0.89
|
17
|
Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection.
|
Genes Immun
|
2008
|
0.89
|
18
|
Role of TNF in cerebral malaria.
|
Lancet
|
1991
|
0.85
|
19
|
Variation in human genes encoding adhesion and proinflammatory molecules are associated with severe malaria in the Vietnamese.
|
Genes Immun
|
2012
|
0.84
|
20
|
Nitric oxide in cerebral malaria.
|
J Infect Dis
|
1995
|
0.83
|
21
|
The pathogenesis of human cerebral malaria.
|
Parasitol Today
|
1994
|
0.81
|
22
|
Sequestration, cytokines, and malaria pathology.
|
Int J Parasitol
|
1994
|
0.79
|
23
|
Enhanced production of reactive nitrogen intermediates in human and murine malaria: reply.
|
Parasitol Today
|
1995
|
0.79
|
24
|
TNF, malaria, and sepsis.
|
Lancet
|
1995
|
0.77
|
25
|
Nitric oxide and cerebral malaria.
|
Lancet
|
1993
|
0.77
|
26
|
Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats.
|
J Neuroimmunol
|
1993
|
0.76
|
27
|
Acidosis in severe childhood malaria.
|
QJM
|
1997
|
0.75
|
28
|
T cells and malarial pathology.
|
Res Immunol
|
1995
|
0.75
|
29
|
[Study of the expression of the interleukin 2 receptor on the lymphocytes of patients with multiple sclerosis using anti-Tac monoclonal antibodies].
|
Pol Tyg Lek
|
1987
|
0.75
|